Searching in FDA · Search everything

Clear filters

33 changes Notice, last 7 days

Favicon for www.regulations.gov

FDA Acknowledgment Letter to Special FX Rentals

The FDA's Center for Devices and Radiological Health (CDRH) has issued an acknowledgment letter to Special FX Rentals. This notice confirms receipt of documentation and does not indicate approval or disapproval of any submissions.

Routine Notice Healthcare
Favicon for www.regulations.gov

FDA Document Details

The Food and Drug Administration (FDA) has published details for a new document on regulations.gov. This notice provides access to the document and its associated information for interested parties. Further details regarding the document's content are available via the provided URL.

Routine Notice Healthcare
Favicon for www.regulations.gov

FDA Document - Copyrighted Content

The FDA has posted a document containing copyrighted content, identified by the docket number FDA-2026-P-2640-0004. The content itself is restricted due to copyright. This notice serves to inform the public of the document's availability and its restricted nature.

Routine Notice Healthcare
Favicon for www.regulations.gov

FDA Variance Approval Letter

The FDA has issued a variance approval letter to Richard Lathrop, authored by CDRH. The letter, which contains restricted personally identifiable information, has been redacted and is available for download.

Routine Notice Healthcare
Favicon for www.regulations.gov

FDA Approves Labeling for RS, ANDA 202682

The U.S. Food and Drug Administration (FDA) has approved labeling for RS, as indicated by ANDA 202682. This approval was posted on March 13, 2026, and pertains to specific drug product labeling.

Routine Notice Pharmaceuticals
Favicon for www.regulations.gov

FDA Approves Labeling for RLD, NDA N021411

The FDA has approved labeling for RLD (Reference Listed Drug) and NDA (New Drug Application) N021411. This notice indicates a regulatory action related to drug approval and labeling requirements.

Routine Notice Healthcare
Favicon for www.regulations.gov

FDA Acknowledgment Letter to Athyna Pharma

The FDA's Center for Drug Evaluation and Research (CDER) has issued an acknowledgment letter to Athyna Pharma, LLC. This notice confirms receipt of a submission from the company.

Routine Notice Healthcare
Favicon for www.regulations.gov

FDA Complaint Document Details

The US Food and Drug Administration (FDA) has posted details regarding a complaint document. The document is available for review, though no specific details about its content or the nature of the complaint are provided in the notice.

Routine Notice Healthcare
Favicon for www.regulations.gov

FDA Acknowledgment Letter to Irish Multimedia, LLC

The FDA has issued an acknowledgment letter to Irish Multimedia, LLC regarding a submission. The letter confirms receipt of the submission but provides no substantive details on its content or purpose.

Routine Notice Healthcare
Favicon for www.regulations.gov

FDA Natural Family Planning Curricula Background Material

The FDA has posted background material related to Natural Family Planning curricula. This notice provides informational resources for interested parties.

Routine Notice Healthcare

Showing 1–10 of 33 changes

1 2 3 4

Get alerts for ""

We'll email you when new changes match this search.

Free. Unsubscribe anytime.